rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2005-12-19
|
pubmed:abstractText |
The purpose of this report is to evaluate the value of urinary hyaluronan (HA) as a maker of residual transitional cell carcinoma (TCC).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0302-2838
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
71-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16310928-Adult,
pubmed-meshheading:16310928-Aged,
pubmed-meshheading:16310928-Aged, 80 and over,
pubmed-meshheading:16310928-Carcinoma, Transitional Cell,
pubmed-meshheading:16310928-Humans,
pubmed-meshheading:16310928-Hyaluronic Acid,
pubmed-meshheading:16310928-Middle Aged,
pubmed-meshheading:16310928-Neoplasm, Residual,
pubmed-meshheading:16310928-Prospective Studies,
pubmed-meshheading:16310928-Tumor Markers, Biological,
pubmed-meshheading:16310928-Urinary Bladder Neoplasms
|
pubmed:year |
2006
|
pubmed:articleTitle |
Urinary hyaluronan as a marker for the presence of residual transitional cell carcinoma of the urinary bladder.
|
pubmed:affiliation |
Disciplina de Urologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, Brazil. carlopasserotti@hotmail.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|